 |
|
Relation Between Medicare Screening Reimbursement and Stage at Diagnosis for Older Patients With Colon Cancer
Cary P. Gross, MD;
Martin S. Andersen, BA;
Harlan M. Krumholz, MD, ScM;
Gail J. McAvay, PhD;
Deborah Proctor, MD;
Mary E. Tinetti, MD
JAMA. 2006;296:2815-2822.
Context Medicare's reimbursement policy was changed in 1998 to provide coverage for screening colonoscopies for patients with increased colon cancer risk, and expanded further in 2001 to cover screening colonoscopies for all individuals.
Objective To determine whether the Medicare reimbursement policy changes were associated with an increase in either colonoscopy use or early stage colon cancer diagnosis.
Design, Setting, and Participants Patients in the Surveillance, Epidemiology, and End Results Medicare linked database who were 67 years of age and older and had a primary diagnosis of colon cancer during 1992-2002, as well as a group of Medicare beneficiaries who resided in Surveillance, Epidemiology, and End Results areas but who were not diagnosed with cancer.
Main Outcome Measures Trends in colonoscopy and sigmoidoscopy use among Medicare beneficiaries without cancer were assessed using multivariate Poisson regression. Among the patients with cancer, stage was classified as early (stage I) vs all other (stages II-IV). Time was categorized as period 1 (no screening coverage, 1992-1997), period 2 (limited coverage, January 1998-June 2001), and period 3 (universal coverage, July 2001-December 2002). A multivariate logistic regression (outcome = early stage) was used to assess temporal trends in stage at diagnosis; an interaction term between tumor site and time was included.
Results Colonoscopy use increased from an average rate of 285/100 000 per quarter in period 1 to 889 and 1919/100 000 per quarter in periods 2 (P<.001) and 3 (P vs 2<.001), respectively. During the study period, 44 924 eligible patients were diagnosed with colorectal cancer. The proportion of patients diagnosed at an early stage increased from 22.5% in period 1 to 25.5% in period 2 and 26.3% in period 3 (P<.001 for each pairwise comparison). The changes in Medicare coverage were strongly associated with early stage at diagnosis for patients with proximal colon lesions (adjusted relative risk period 2 vs 1, 1.19; 95% confidence interval, 1.13-1.26; adjusted relative risk period 3 vs 2, 1.10; 95% confidence interval, 1.02-1.17) but weakly associated, if at all, for patients with distal colon lesions (adjusted relative risk period 2 vs 1, 1.07; 95% confidence interval, 1.01-1.13; adjusted relative risk period 3 vs 2, 0.97; 95% confidence interval, 0.90-1.05).
Conclusions Expansion of Medicare reimbursement to cover colon cancer screening was associated with an increased use of colonoscopy for Medicare beneficiaries, and for those who were diagnosed with colon cancer, an increased probability of being diagnosed at an early stage. The selective effect of the coverage change on proximal colon lesions suggests that increased use of whole-colon screening modalities such as colonoscopy may have played a pivotal role.
Author Affiliations: Sections of General Internal Medicine (Dr Gross), Cardiovascular Medicine (Dr Krumholz), Geriatrics (Drs McAvay and Tinetti), and Gastroenterology (Dr Proctor), Department of Medicine, Robert Wood Johnson Clinical Scholars Program (Drs Gross and Krumholz), Department of Epidemiology and Public Health (Mr Andersen and Dr Krumholz), Yale University School of Medicine, New Haven, Conn.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Medicare Policy and Colorectal Cancer Screening: Will Changing Access Change Outcomes?
Arden M. Morris
JAMA. 2006;296(23):2855-2856.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Socioeconomic and Racial Patterns of Colorectal Cancer Screening among Medicare Enrollees in 2000 to 2005
Doubeni et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2170-2175.
ABSTRACT
| FULL TEXT
Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
Croswell et al.
Ann Fam Med 2009;7:212-222.
ABSTRACT
| FULL TEXT
Patient and Physician Reminders to Promote Colorectal Cancer Screening: A Randomized Controlled Trial
Sequist et al.
Arch Intern Med 2009;169:364-371.
ABSTRACT
| FULL TEXT
Policy Research: Using Evidence to Improve Healthcare Delivery Systems
Ross and Gross
Circulation 2009;119:891-898.
FULL TEXT
Association of Colonoscopy and Death From Colorectal Cancer
Baxter et al.
ANN INTERN MED 2009;150:1-8.
ABSTRACT
| FULL TEXT
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Meyskens et al.
Cancer Prevention Research 2008;1:32-38.
ABSTRACT
| FULL TEXT
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Levin et al.
CA Cancer J Clin 2008;58:130-160.
ABSTRACT
| FULL TEXT
Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model
Brader et al.
Molecular Cancer Therapeutics 2007;6:2900-2908.
ABSTRACT
| FULL TEXT
Why Hasn't This Patient Been Screened for Colon Cancer? An Iowa Research Network Study
Levy et al.
J Am Board Fam Med 2007;20:458-468.
ABSTRACT
| FULL TEXT
Changes in Health Care Expenditure Associated with Gaining or Losing Health Insurance
Ward and Franks
ANN INTERN MED 2007;146:768-774.
ABSTRACT
| FULL TEXT
Medicare Reimbursement for Colonoscopy
JWatch Oncology and Hematology 2007;2007:2-2.
FULL TEXT
Screening Colonoscopy Linked to Earlier-Stage Diagnoses
JWatch Gastroenterology 2007;2007:1-1.
FULL TEXT
Medicare Policy and Colorectal Cancer Screening: Will Changing Access Change Outcomes?
Morris
JAMA 2006;296:2855-2856.
FULL TEXT
|
